These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7426025)

  • 21. Ligand-dependent reactivity of (Na+ + K+)-ATPase with showdomycin.
    Hara S; Hara Y; Nakao T; Nakao M
    Biochim Biophys Acta; 1981 Jun; 644(1):53-61. PubMed ID: 6266464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transport of two non-metabolized nucleosides, deoxycytidine and cytosine arabinoside, in a sub-line of the L1210 murine leukemia.
    Kessel D; Shurin SB
    Biochim Biophys Acta; 1968 Sep; 163(2):179-87. PubMed ID: 5686275
    [No Abstract]   [Full Text] [Related]  

  • 23. Structure-activity relationships of anthracyclines relative to cytotoxicity and effects on macromolecular synthesis in L1210 leukemia cells.
    Matsuzawa Y; Oki T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1981 Dec; 34(12):1596-607. PubMed ID: 6949896
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison between the inhibitory activities of sangivamycin and thiosangivamycin on nuclear ribonucleic acid synthesis in L1210 cells in vitro.
    Glazer RI; Peale AL
    Biochem Pharmacol; 1980 Feb; 29(3):305-10. PubMed ID: 7362643
    [No Abstract]   [Full Text] [Related]  

  • 25. Antitumor activity and some pharmacologic properties of anthramycin methyl ether.
    Adamson RH; Hart LG; DeVita VT; Oliverio VT
    Cancer Res; 1968 Feb; 28(2):343-7. PubMed ID: 5641523
    [No Abstract]   [Full Text] [Related]  

  • 26. Mechanism of action of showdomycin. V. Reduced ability of showdomycin-resistant mutants of Escherichia coli K-12 to take up showdomycin and nucleosides.
    Komatsu Y
    J Antibiot (Tokyo); 1971 Dec; 24(12):876-83. PubMed ID: 4946509
    [No Abstract]   [Full Text] [Related]  

  • 27. Novel nucleoside transport inhibitors of natural origin.
    Zhen YS; Su J; Xue YC; Qi CQ; Hu JL
    Adv Exp Med Biol; 1994; 370():779-82. PubMed ID: 7661021
    [No Abstract]   [Full Text] [Related]  

  • 28. N-Methylformycins. Reactivity with adenosine deaminase, incorporation into intracellular nucleotides of human erythrocytes and L 1210 cells and cytotoxicity to L 1210 cells.
    Crabtree GW; Agarwal RP; Parks RE; Lewis AF; Wotring LL; Townsend LB
    Biochem Pharmacol; 1979 May; 28(9):1491-500. PubMed ID: 475858
    [No Abstract]   [Full Text] [Related]  

  • 29. The determination of the uptake of arabinosyl-6-mercaptopurine by L1210 cells.
    Chao DL; Kimball AP
    Biochim Biophys Acta; 1972 Jun; 266(3):721-5. PubMed ID: 5040251
    [No Abstract]   [Full Text] [Related]  

  • 30. Enhancement by caffeine of neocarzinostatin cytotoxicity in murine leukemia L1210 cells.
    Tatsumi K; Tashima M; Shirakawa S; Nakamura T; Uchino H
    Cancer Res; 1979 May; 39(5):1623-7. PubMed ID: 154973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nucleoside antibiotics. Asymmetric incorporation of glutamic acid and acetate into the maleimide ring of showdomycin by Streptomyces showdoensis.
    Elstner EF; Suhadolnik RJ
    Biochemistry; 1972 Jul; 11(14):2578-84. PubMed ID: 5045517
    [No Abstract]   [Full Text] [Related]  

  • 32. Degradation and intracellular phosphorylation of showdomycin.
    Arendes J; Zahn RK; Hantke E; Müller WE
    Cancer Lett; 1978 May; 4(5):259-64. PubMed ID: 657123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of nucleoside-binding sites by nucleoside analogues in Escherichia coli.
    Doskocil J; Holý A
    Nucleic Acids Res; 1974 Mar; 1(3):491-502. PubMed ID: 10793681
    [No Abstract]   [Full Text] [Related]  

  • 34. Biochemical and pharmacological effects of the fermentation-derived antitumor agent, (alphaS,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125).
    Neil GL; Berger AE; McPartland RP; Grindey GB; Bloch A
    Cancer Res; 1979 Mar; 39(3):852-6. PubMed ID: 427775
    [No Abstract]   [Full Text] [Related]  

  • 35. Antileukemic activity of synthetic daunomycinone derivatives bearing modifications in the glycosidic moiety.
    Perchellet EM; Sperfslage BJ; McIlvain CJ; Aligiannis N; Pouli N; Marakos P; Skaltsounis AL; Perchellet JP
    Anticancer Res; 2001; 21(6A):3957-67. PubMed ID: 11911277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of aclacinomycin B on biological macromolecular contents and synthesis of L1210 cells].
    Li ZR; Feng JB; Liang F; Zeng SX; Han R
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Jun; 6(3):174-8. PubMed ID: 6241042
    [No Abstract]   [Full Text] [Related]  

  • 37. Discovery of the Showdomycin Gene Cluster from Streptomyces showdoensis ATCC 15227 Yields Insight into the Biosynthetic Logic of C-Nucleoside Antibiotics.
    Palmu K; Rosenqvist P; Thapa K; Ilina Y; Siitonen V; Baral B; Mäkinen J; Belogurov G; Virta P; Niemi J; Metsä-Ketelä M
    ACS Chem Biol; 2017 Jun; 12(6):1472-1477. PubMed ID: 28418235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multifactorial cellular determinants of the action of antimetabolites.
    Rustum YM; Grindey GB; Hakala MT; Mihich E
    Adv Enzyme Regul; 1976; 14():281-95. PubMed ID: 184698
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of maleimide derivatives, sulfhydryl reagents, on stimulation of neutrophil superoxide anion generation with concanavalin A.
    Yamashita T
    FEBS Lett; 1983 Dec; 164(2):267-71. PubMed ID: 6317451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mode of action of azotomycin.
    Brockman RW; Pittillo RF; Shaddix S; Hill DL
    Antimicrob Agents Chemother (Bethesda); 1969; 9():56-62. PubMed ID: 4919007
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.